Business
Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference in New York
BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces that it will present at the Jefferies Global Healthcare Conference taking place in New York City. Ivor Elrifi, Chief Executive Officer and Keeren Shah, Chief Operating and Financial Officer of Tiziana Life Sciences, will deliver a corporate presentation highlighting the
About this update from Tiziana Life Sciences Ltd
[{"type":"image","alt":"Tiziana Life Sciences Ltd.","displaySize":"","headline":null,"caption":"Tiziana Life Sciences Ltd.","className":"","disableSlideshowImg":false,"size":{"original":{"width":264,"height":60,"url":"https://media.zenfs.com/en/globenewswire.com/08f5d705b5df39888a6496fd7522f947"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/.dsSY9JuiKya2zvW4QVPJg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTk1/https://media.zenfs.com/en/globenewswire.com/08f5d705b5df39888a6496fd7522f947","width":264,"height":60},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/.dsSY9JuiKya2zvW4QVPJg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTk1/https://media.zenfs.com/en/globenewswire.com/08f5d705b5df39888a6496fd7522f947","width":264,"height":60}},"lazy":false},{"type":"text","content":"BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces that it will present at the Jefferies Global Healthcare Conference taking place in New York City. Ivor Elrifi, Chief Executive Officer and Keeren Shah, Chief Operating and Financial Officer of Tiziana Life Sciences, will deliver a corporate presentation highlighting the Company’s recent clinical and corporate updates.","length":553,"tagName":"p"},{"type":"text","content":"Presentation Details:Event: Jefferies Global Healthcare ConferenceDate: Thursday, June 4, 2026Time: 10:30 – 11:00 AM ETLocation: New York, NY","length":145,"tagName":"p"},{"type":"text","content":"The presentation will be followed by a question-and-answer session with institutional investors.","length":96,"tagName":"p"},{"type":"text","content":"“We are pleased to participate in the Jefferies Global Healthcare Conference and look forward to sharing our recent progress with the investment community,” said Ivor Elrifi, Chief Executive Officer of Tiziana Life Sciences. “This is an important time for the Company as we advance multiple clinical programs, and we welcome the opportunity to provide an update on our strategic direction and upcoming milestones.”","length":414,"tagName":"p"},{"type":"text","content":"About Foralumab","length":15,"tagName":"p"},{"type":"text","content":"Foralumab, a fully human anti-CD3 monoclonal antibody, is a biologic candidate that has been shown to stimulate T regulator...